Prognostic study of XELOX regimen supplemented with Fuzheng Yiliu Tang in the treatment of advanced gastric cancer
Objective:To explore the clinical effect of XELOX regimen(oxaliplatin+capecitabine)supplemented with Fuzheng Yiliu Decoction in the treatment of advanced gastric cancer.Methods:90 patients diagnosed with advanced gastric cancer in the oncology department from January 2020 to December 2022 were collected and randomly divided into a traditional Chinese medicine group and a control group.Both received XELOX regimen chemotherapy,and the traditional Chinese medicine group was additionally treated with Fuzheng Yiliu Decoction..The differences in tumor markers,incidence of adverse reactions,quality of life scores and survival rates between the two groups of patients were observed.Results:After treatment,the levels of tumor markers CEA and AFP in the traditional Chinese medicine group were significantly reduced,and the life treatment score of the traditional Chinese medicine group was significantly improved,both of which were significantly better than those in the control group.The incidence of adverse reactions in the traditional Chinese medicine group was significantly higher than that in the control group.Conclusion:Fuzheng Yiliu Decoction can improve the adverse reactions of patients with advanced gastric cancer,reduce serum tumor marker levels,and prolong the survival of patients.
Advanced gastric cancerFuzheng Yiliu DecoctionAdverse reactionsQuality of lifeSurvival analysis
国家科技期刊平台
NSTL
万方数据
